Cargando…

Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey

Between January and March 2022, WHO conducted a global online survey to collect data on diagnostic capacities and treatment practices in different settings for four implantation mycoses: eumycetoma, actinomycetoma, cutaneous sporotrichosis and chromoblastomycosis. The survey investigated the type of...

Descripción completa

Detalles Bibliográficos
Autores principales: Milani, Barbara, Dagne, Daniel Argaw, Choi, Hye Lynn, Schito, Marco, Stone, Heather Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335693/
https://www.ncbi.nlm.nih.gov/pubmed/37379338
http://dx.doi.org/10.1371/journal.pntd.0011443
_version_ 1785071052842336256
author Milani, Barbara
Dagne, Daniel Argaw
Choi, Hye Lynn
Schito, Marco
Stone, Heather Anne
author_facet Milani, Barbara
Dagne, Daniel Argaw
Choi, Hye Lynn
Schito, Marco
Stone, Heather Anne
author_sort Milani, Barbara
collection PubMed
description Between January and March 2022, WHO conducted a global online survey to collect data on diagnostic capacities and treatment practices in different settings for four implantation mycoses: eumycetoma, actinomycetoma, cutaneous sporotrichosis and chromoblastomycosis. The survey investigated the type of diagnostic methods available in countries at various health system levels (tertiary, secondary, primary level) and the medicines used to treat implantation mycoses, with a view to understanding the level of drug repurposing for treatment of these diseases. 142 respondents from 47 countries, including all continents, contributed data: 60% were from middle-income countries, with 59% working at the tertiary level of the health system and 30% at the secondary level. The results presented in this article provide information on the current diagnostic capacity and treatment trends for both pharmacological and non-pharmacological interventions. In addition, the survey provides insight on refractory case rates, as well as other challenges, such as availability and affordability of medicines, especially in middle-income countries. Although the study has limitations, the survey-collected data confirms that drug repurposing is occurring for all four surveyed implantation mycoses. The implementation of an openly accessible global and/or a national treatment registry for implantation mycoses could contribute to address the gaps in epidemiological information and collect valuable observational data to inform treatment guidelines and clinical research.
format Online
Article
Text
id pubmed-10335693
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-103356932023-07-12 Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey Milani, Barbara Dagne, Daniel Argaw Choi, Hye Lynn Schito, Marco Stone, Heather Anne PLoS Negl Trop Dis Research Article Between January and March 2022, WHO conducted a global online survey to collect data on diagnostic capacities and treatment practices in different settings for four implantation mycoses: eumycetoma, actinomycetoma, cutaneous sporotrichosis and chromoblastomycosis. The survey investigated the type of diagnostic methods available in countries at various health system levels (tertiary, secondary, primary level) and the medicines used to treat implantation mycoses, with a view to understanding the level of drug repurposing for treatment of these diseases. 142 respondents from 47 countries, including all continents, contributed data: 60% were from middle-income countries, with 59% working at the tertiary level of the health system and 30% at the secondary level. The results presented in this article provide information on the current diagnostic capacity and treatment trends for both pharmacological and non-pharmacological interventions. In addition, the survey provides insight on refractory case rates, as well as other challenges, such as availability and affordability of medicines, especially in middle-income countries. Although the study has limitations, the survey-collected data confirms that drug repurposing is occurring for all four surveyed implantation mycoses. The implementation of an openly accessible global and/or a national treatment registry for implantation mycoses could contribute to address the gaps in epidemiological information and collect valuable observational data to inform treatment guidelines and clinical research. Public Library of Science 2023-06-28 /pmc/articles/PMC10335693/ /pubmed/37379338 http://dx.doi.org/10.1371/journal.pntd.0011443 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Milani, Barbara
Dagne, Daniel Argaw
Choi, Hye Lynn
Schito, Marco
Stone, Heather Anne
Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey
title Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey
title_full Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey
title_fullStr Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey
title_full_unstemmed Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey
title_short Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey
title_sort diagnostic capacities and treatment practices on implantation mycoses: results from the 2022 who global online survey
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335693/
https://www.ncbi.nlm.nih.gov/pubmed/37379338
http://dx.doi.org/10.1371/journal.pntd.0011443
work_keys_str_mv AT milanibarbara diagnosticcapacitiesandtreatmentpracticesonimplantationmycosesresultsfromthe2022whoglobalonlinesurvey
AT dagnedanielargaw diagnosticcapacitiesandtreatmentpracticesonimplantationmycosesresultsfromthe2022whoglobalonlinesurvey
AT choihyelynn diagnosticcapacitiesandtreatmentpracticesonimplantationmycosesresultsfromthe2022whoglobalonlinesurvey
AT schitomarco diagnosticcapacitiesandtreatmentpracticesonimplantationmycosesresultsfromthe2022whoglobalonlinesurvey
AT stoneheatheranne diagnosticcapacitiesandtreatmentpracticesonimplantationmycosesresultsfromthe2022whoglobalonlinesurvey